CN1911115A - Four-in-one health-care beverage - Google Patents

Four-in-one health-care beverage Download PDF

Info

Publication number
CN1911115A
CN1911115A CNA2006100481539A CN200610048153A CN1911115A CN 1911115 A CN1911115 A CN 1911115A CN A2006100481539 A CNA2006100481539 A CN A2006100481539A CN 200610048153 A CN200610048153 A CN 200610048153A CN 1911115 A CN1911115 A CN 1911115A
Authority
CN
China
Prior art keywords
kilograms
group
sea
health
pilose antler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2006100481539A
Other languages
Chinese (zh)
Other versions
CN1911115B (en
Inventor
武生禄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200610048153A priority Critical patent/CN1911115B/en
Publication of CN1911115A publication Critical patent/CN1911115A/en
Application granted granted Critical
Publication of CN1911115B publication Critical patent/CN1911115B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A 4-element health-care beverage is prepared from antler, red jujube, wolfberry fruit and seabuckthorn fruit through low-temp extracting, mixing and adding water.

Description

Four-in-one health-care beverage
Technical field
The present invention relates to a kind of beverage, be specially a kind of four-in-one health-care beverage.
Background technology
The patent No. is 021176833 to disclose a kind of beverage formula and manufacture craft, mainly be various raw materials to be mixed back heat in water extract, and allocated a kind of beverage that forms with white sugar with part health care, yet find in practice, though the product mouthfeel of utilizing this technology to obtain is fine, active matter runs off serious; Vitamin, amino acid etc. can only effectively extract 40-55%, and the function of health nutrient, the aspect of building up health is inadequate.
Summary of the invention
The present invention is in order to solve the beverage function singleness that exists in the prior art, and active material runs off serious, the unconspicuous problem of health care and a kind of four-in-one health-care beverage is provided.
The present invention is realized by following technical scheme: a kind of four close health drink, are that pilose antler, red date, matrimony vine, sea-buckthorn and water are formed by raw material; Needing with raw material in the product per ton is the following weight ratio example, 8~12 kilograms in pilose antler, 60~80 kilograms of red dates, 15~25 kilograms of matrimony vines, 50~90 kilograms of sea-buckthorns, and all the other are the water composition.Processing technology:
(1) after pilose antler was pulverized, at 0~20 ℃, intensity of illumination be (0.5~30 lux) time lixiviate 35~48 hours, filter extract; (2) red date is pulverized the back at 0~20 ℃, and intensity of illumination be (0.5~30 lux) following lixiviate 35~48 hours, filter extract; (3) after matrimony vine was pulverized, at 0~20 ℃, intensity of illumination be (0.5~30 lux) time lixiviate 35~48 hours, filter extract; (4) sea-buckthorn directly squeezes into juice, and the extract of four kinds of raw materials mixes, and not enough amount water is supplied and got final product.
Pilose antler is the treasured among the Triratna of northeast, and it is famous and precious human body tonic medicine, has the special efficacy that beneficial gas is kept fit.Pilose antler is promptly included in Shennong's Herbal as rare Chinese medicine.Put down in writing in the Compendium of Material Medica that the big physician's Li Shizhen (1518-1593 A.D.) of the Ming Dynasty is shown: pilose antler " nontoxic, the beneficial gas lofty ideal of the sweet temperature of smell, production of sperm are mended marrow, the Yiyang of nourishing blood, strengthening the muscles and bones, control all deficient diseases ".Pilose antler is used for treating impotence, dizziness, tinnitus, neurasthenia, insomnia, waist knee flaccidity, the inferior disease of women's cold of insufficiency type band clinically.Modern science proves, contains several amino acids in the pilose antler, but wherein contains lysine, phenylalanine, leucine, isoleucine, methionine, valine, the threonine that can not synthesize in body of needed by human.
The fruit of Chinese wolfberry is good medicine commonly used, and nature and flavor are sweet flat, go into liver, lung, kidney three warps, the usefulness that have nourishing kidney and replenishing pneuma, nourishes the liver to improve visual acuity.Its son is a tonic, and root is the logical medicine of a warm nature.Son is useful for that the liver stomach-Yin is lost, impotence and seminal emission, order are stuck with paste dizzy.Root is used for hectic fever due to yin deficiency, hectic fever due to yin night sweat, the spleen-heat syndrome spitting of blood.Carry according to Compendium of Material Medica: the hard muscles and bones of energy, anti-old, remove wind, remove consumptive disease, mend vital essence.It is pained to cure mainly the worry dry throat, goes yearningly and drinks, and rushes down the kidney fire.Nourshing kidney profit liver, oil expression is lit a lamp, and makes eye bright.Matrimony vine has the blood sugar of reduction, lipotropy, and can antiatherosclerosis.Function tonification liver kidney, benefiting shrewd head during as Chinese medicine.Cure mainly diseases such as dizzy dim, many tear, the soreness of waist of suffering from a deficiency of the kidney.The root skin has step-down, brings down a fever, bacteriostasis, and function clearing heat and cooling blood, reducing the asthenic fever cure mainly diseases such as deficient fever, hematuria.Known Chinese wolfberry fruit contains betaine, maize quality, wintercherry haematochrome and fatty wet goods; The root skin contains betaine, sitosterol and vitamin B1.The lycium barbarum fruit also contains betaine, wintercherry haematochrome etc.Sea-buckthorn Hippophae rhamnoides has another name called vinegar willow, acid thorn for the Elaeangnaceae plant, is Elaeangnaceae acid thorn platymiscium, and fallen leaves Right wood mainly is distributed in the Eurasia, is the main producing region in the three northern areas of China of China.Have very high edible and medical value, the chemical composition in the sea-buckthorn is a lot, comprises amino acid, vitamin, carbohydrate, glucoside and trace element.Chromocor compound is the main biological activity in the sea-buckthorn, and Hippophate flavone particularly wherein Isorhamnetin has certain curative effect to cardiovascular and cerebrovascular disease, especially to angina pectoris and the heart function effect that has clear improvement.
The extracting method that relates in the beverage of the present invention, under lower temperature, respectively pilose antler, red date, matrimony vine water are extracted, optionally obtained useful composition and activity that health functions is arranged most in each raw material, given full play to health-care effect health.
One, the zoopery of alleviating physical fatigue function:
Table 1 the present invention is to the influence of swimming with a load attached to the body group mouse body weight
Group Dosage ml/kg.bw Body weight during grouping (g) 1.2 Body weight (g) before the swimming 1.3
Dosage group high dose group in the normal control group low dose group 0.6 3.0 9.0 19.5±0.9(15) 19.3±1.0(15) 19.1±1.1(15) 19.3±1.0(15) 43.9±3.1(15) 40.8±4.1(15) 42.7±3.5(15) 41.1±3.8(14)
Table 2 the present invention is to the influence of urea nitrogen group mouse body weight
Group Dosage ml/kg.bw Body weight during grouping (g) 1.2 Body weight (g) before the swimming 1.3
Dosage group high dose group in the normal control group low dose group 0.6 3.0 9.0 19.3±1.2(15) 19.5±1.1(15) 19.5±1.2(15) 19.3±1.2(15) 44.5±3.2(15) 44.0±2.4(15) 44.7±3.5(15) 46.9±3.5(14)
Table 3 the present invention is to the influence of lactic acid group mouse body weight
Group Dosage ml/kg.bw Body weight during grouping (g) 1.2 Body weight (g) before the swimming 1.3
Dosage group high dose group in the normal control group low dose group 0.6 3.0 9.0 19.3±1.2(15) 19.3±1.1(15) 19.5±1.2(15) 19.3±1.2(15) 44.5±3.1(15) 39.9±2.2(15) 40.4±2.9(15) 40.0±3.4(14)
Table 4 the present invention is to the influence of mouse swimming time
Group Dosage ml/kg.bw The animal number of elements Swimming time
Dosage group high dose group in the normal control group low dose group 0.6 3.0 9.0 15 15 15 15 24.1±22.2 32.3±40.1 41.3±46.9 71.0±45.5
Table 5 is the influence of the present invention to the mice serum urea nitrogen
Group (mmol/L) Dosage ml/kg.bw The animal number of elements The serum urea nitrogen content
Dosage group high dose group in the normal control group low dose group 0.6 3.0 9.0 15 15 15 15 10.53±1.25 1043±0.99 9.51±1.18 9.34±1.32
Table 6 the present invention is to the influence of mouse blood lactate level
Group Dosage ml/kg.bw Blood lactic acid content before the swimming Swimming back blood lactic acid content Blood lactic acid content after 20 minutes Peak area under the blood lactic acid curve
Dosage group high dose group in the normal control group low dose group 0.6 3.0 9.0 1.61±0.61 1.51±0.56 1.53±0.46 1.54±0.54 5.01±1.79 4.06±1.15 3.55±1.00 * 3.44±0.62 * 2.02±0.56 2.12±0.47 2.19±0.60 2.37±0.48 103.4±27.2 89.7±17.8 82.8±19.0 * 83.1±11.1 *
Table 7 the present invention is to the influence of Mouse Liver glycogen content
Group Dosage (ml/kg.bw) Number of animals (only) Hepatic glycogen content (mg/100g)
Dosage group high dose group in the normal control group low dose group 0.6 3.0 9.0 15 15 15 15 1177.0±555.7 1195.8±653.9 1345.7±489.7 3068.9±752.9
Product people's of the present invention recommendation dose is 1 tin of every day, be equivalent to per kilogram of body weight 3.0ml, animal used as test is selected from 180 of Male Kunming strain mice, body weight 18~22 grams, according to 10 times of concentrate meters of this product, people's every day, oral consumption was per kilogram of body weight 3.0ml, and the dosage (by 10 times of concentrates of this product) that gives the mouse animal subject is respectively: middle dosage 3.0ml/kgbw, high dose is 9.0ml/kgbw, and low dosage is 0.6ml/kgbw; After 30 days, compare for mouse continuously with the normal control group through mouthful filling stomach beverage of the present invention, after the swimming, high dose group mouse swimming time obviously prolongs; The blood urea nitrogen (BUN) conspicuousness of high dose group mouse reduces, and high dose group Mouse Liver glycogen content significantly increases; At once, the blood lactose content conspicuousness of middle high dose group mouse reduces after the swimming; Peak area is less than control group under the blood lactic acid curve of middle high dose group mouse.
Two, strengthen the zoopery of immunocompetence function:
Table 8 the present invention cleans up the influence of ability to carbon
Dosage Number of animals (only) Phagocytic index The P value
0ml/kg.bw12 1.5ml/kg.bw 3.0ml/kg.bw 9.0ml/kg.bw 12 12 12 12 6.36±0.74 7.11±0.61 7.03±0.57 7.04±0.62 ------ 0.017 0.037 0.033
Table 9 the present invention is to the influence of mouse delayed allergy ability
Dosage Number of animals (only) Swelling degree of the paw (mm) The P value
0ml/kg.bw 1.5ml/kg.bw 3.0ml/kg.bw 9.0ml/kg.bw 12 12 12 12 0.57±0.17 0.64±0.17 0.71±0.17 0.75±0.14 ------ 0.640 0.104 0.028
Table 10 the present invention is to the influence of mouse lymphocyte transformation experiment
Dosage Number of animals (only) The lymphopoiesis ability The P value
0ml/kg.bw 1.5ml/kg.bw 3.0ml/kg.bw 9.0ml/kg.bw 12 12 12 12 0.176±0.048 0.211±0.056 0.222±0.48 0.225±0.040 ------ 0.202 0.066 0.042
Table 11 the present invention engulfs the influence of chicken red blood cell index to mouse macrophage
Dosage Number of animals (only) The lymphopoiesis ability The P value
0ml/kg.bw 1.5ml/kg.bw 3.0ml/kg.bw 9.0ml/kg.bw 12 12 12 12 0.56±0.22 0.64±0.24 0.80±0.28 0.83±0.26 ------ 0.769 0.065 0.033
Oral administration gives the beverage of the present invention 30 days of various dose, compares with the 0ml/kgBW group, and this animal subject can improve mouse carbon in the 1.5ml/kgBW group and clean up index (P<0.05).Can improve mouse carbon in the 3.0ml/kgBW group and clean up index (P<0.05), can improve the delayed allergy ability (P<0.05) of mouse in the 9.0ml/kgBW group, strengthen the mouse lymphocyte conversion capability (P<0.05) that ConA induces, improve the carbon of mouse and clean up ability (P<0.05), improve the huge chicken red blood cell phagocytic index (P<0.05) of biting of mouse, each dosage group mouse body weight does not all have significant difference.According to " health food check with assessment technique standard " (2003 editions) to the criterion that strengthens the immunity health food as can be known, this invention has the function that strengthens immunity.
Three, security zoopery:
Material and method:
1.1 tried thing: beverage human body of the present invention uses recommended amounts to be the 180ml/ day for human beings, be 3ml/kg.bw, add in this check high dose group that to be tried thing be to concentrate one times again on the basis of 10 times of concentrates of the present invention, middle low dose group is then directly tested with 10 times of concentrates of the present invention, concentrated mode is a heating evaporation, temperature is 85 ℃
1.2 experimental animal is cleaning level wistar rat,
1.3 dosage grouping
Establish three dosage groups with 10 times, 50 times, 100 times of recommended amounts, be equivalent to beverage 30ml/kg.bw of the present invention, 150ml/kg.bw, 300ml/kg.bw, other establishes negative control group.
1.4 give the thing approach that tried
To be tried thing mixes in the basal feed and feeds, according to rat body weight 10% the estimation animal food-intake, add corresponding concentrate 30ml (10 times of concentrates), 150ml (10 times of concentrates) and 150ml (20 times of concentrates) in the feed of the basic, normal, high dosage group of per kilogram respectively.Control group gives basal feed.
1.5 operating procedure: select body weight 65~80 gram from small rat, male and female half and half are divided into four groups at random by body weight, i.e. control group and three dosage groups, and single cage is raised, and feeds continuously 30 days.Experimental session, animal freely ingests and drinks water, and observes and write down general performance, behavior, poisoning symptom and the death condition of animal every day.Claim body weight weekly one time, record food intake quantum calculates food utilization.Got hematological indices such as tail hematometry hemoglobin, red blood cell count(RBC), white blood cell count(WBC), leukocyte differential count on the 30th day; Fasting 16 hours, broken end was got hematometry serum glutamic pyruvic transminase (GPT), glutamic-oxalacetic transaminease (GOT) urea nitrogen (BUN) creatinine (CRE) blood sugar (GLOC) glyceric acid fat (TRIG), T-CHOL (CROL) total protein (TPRO) albumin biochemical indicators such as (ALB) in the 31st day, dissect the animal internal organs such as liver spleen kidney stomach and intestine of coring, observation changes substantially and weighs, calculate dirty body ratio, and the important organ of each group is carried out pathologic finding.
Laboratory test results
Table 12 the present invention is to the influence of rat body weight
Sex Group ml/kg Number of animals (only) starting weight First week Second week The 3rd week Around
Female Contrast 30 150 300 10 10 10 10 72.2±4.6 70.6±4.2 70.6±3.9 70.6±3.8 117.0±5.4 116.0±6.2 111.1±4.6 113.7±5.0 147.6±14.3 152.2±4.7 142.4±9.6 141.5±7.0 171.8±14.4 179.7±6.8 170.8±10.7 167.7±9.8 191.5±13.3 198.1±7.0 196.5±11.7 188.7±11.8
The P value 0.7734 0.0814 0.0604 0.0990 0.1282
Male Contrast 30 150 300 P values 10 10 10 10 72.5±4.1 72.6±4.2 72.7±4.1 72.4±3.6 0.5318 112.0±6.4 112.4±4.5 110.9±8.9 102.4±6.9 0.0715 157.6±10.9 158.4±7.1 155.8±14.2 153.3±4.8 0.8094 181.9±14.2 179.6±19.0 191.2±16.2 176.9±15.6 0.3528 215.7±19.9 223.2±16.1 222.8±19.1 211.2±23.1 0.4645
Table 13 the present invention is to the influence of rat total foodstuff utilization rate
Sex Group ml/kg Number of animals (only) Weight gain Food-intake Food utilization
Female Contrast 30 150 300 P values 10 10 10 10 119.3±12.0 127.5±6.4 115.9±9.7 118.1±10.0 0.0602 442.1±10.8 452.4±17.5 446.8±11.8 456.1±30.5 0.3949 27.0±2.5 28.2±1.4 25.9±2.0 25.9±2.1 0.0569
Male Contrast 30 150 300 P values 10 10 10 10 143.2±17.4 150.6±12.9 150.1±16.1 138.8±20.9 0.3585 505.6±10.8 505.4±23.6 508.2±24.2 519.6±30.9 0.6433 28.3±2.5 19.8±2.4 25.9±2.9 26.7±3.6 0.0813
Pass through variance analysis as can be seen by table 12 and table 13, each dosage group body weight aspect such as food utilization and control group relatively there are no significant difference, thing is taken food to animal and food utilization all has no adverse effects illustrate that of the present invention this tried.
Table 14 the present invention learns the index influence to rat blood
Sex Group ml/kg Number of animals (only) Hemoglobin g/L Red blood cell count(RBC) * 10 12/L White blood cell count(WBC) * 10 12/L Lymphocyte % Neutrophil leucocyte % Other %
Female Contrast 30 150 300 P values 10 10 10 10 145.4±6.7 145.8±10.7 147.1±6.5 147.3±7.5 0.9939 7.12±0.51 7.59±0.95 6.79±0.63 6.89±0.83 0.1000 20.41±6.25 21.66±3.20 18.87±4.57 21.06±3.88 0.5723 79.9±5.2 84.5±5.4 85.1±4.6 82.5±5.7 0.1313 18.0±4.0 14.3±5.4 13.5±3.2 16.4±5.8 0.1527 2.1±1.5 1.2±1.1 1.4±2.3 1.1±1.1 0.5035
Male Contrast 30 150 300 P values 10 10 10 10 151.8±10.6 148.5±7.4 150.3±7.3 147.3±7.5 0.6646 6.89±0.69 7.17±0.88 6.97±0.49 6.80±0.64 0.8069 23.20±3.29 22.96±7.35 24.31±3.84 25.25±4.99 0.7332 80.8±6.7 80.3±10.3 83.0±5.6 82.7±5.7 0.7966 17.9±5.9 18.6±10.5 15.7±4.4 15.8±5.9 0.7296 1.3±1.2 1.1±1.0 1.3±1.4 1.5±1.3 0.9099
Table 15 the present invention influences 1 to the rat biochemical indicator
Sex Group ml/kg Number of animals (only) GPT U/L GOT U/L RUN mmol/L CRE μmol/L GLUC mmol/L
Female Contrast 30 150 300 P values 10 10 10 10 25.13±3.23 24.40±10.27 24.57±4.02 26.08±5.97 0.9367 122.84±12.85 137.40±12.14 129.52±38.16 136.78±8.61 0.3937 7.76±0.66 7.76±0.98 7.51±0.73 7.43±0.70 0.6878 39.88±7.09 42.16±4.63 41.11±7.39 41.66±12.82 0.9403 5.04±0.73 4.55±0.44 4.52±0.57 4.29±0.62 0.0532
Male Contrast 30 150 300 P values 10 10 10 10 33.30±6.83 32.33±6.94 34.87±5.04 31.66±6.93 0.7108 143.99±22.61 144.70±20.42 138.20±30.53 134.46±23.63 0.7580 8.02±1.29 8.19±0.97 8.89±1.59 7.87±0.73 0.2424 48.53±7.34 50.55±8.02 53.15±9.52 45.2±64.53 0.1409 3.77±0.76 3.47±0.49 4.04±0.47 4.06±0.44 0.0790
Table 16 the present invention is to rat biochemical indicator assay 2
Sex Group ml/kg Number of animals (only) TRIG mmol/L CHOL mmol/L TPRO g/L ALB g/L A/G
Female Contrast 30 150 300 P values 10 10 10 10 1.05±0.29 1.12±0.29 0.91±0.32 1.08±0.30 0.4125 1.89±0.27 1.65±0.21 1.85±0.25 2.00±0.43 0.0901 71.28±2.41 73.58±4.87 74.12±3.15 73.34±4.31 0.3763 36.04±2.12 37.84±1.20 37.58±1.52 36.08±2.17 0.0522 1.64±0.15 1.080±.17 1.04±0.12 0.98±0.11 0.4613
Male Contrast 30 150 300 P values 10 10 10 10 1.06±0.26 1.11±0.26 0.95±0.20 1.12±0.29 0.4743 2.00±0.34 1.83±0.25 2.05±0.37 1.87±0.36 0.4265 71.24±4.73 70.23±5.07 71.14±4.22 68.82±3.49 0.6723 32.85±1.55 33.29±2.32 31.74±3.00 31.16±2.78 0.1973 0.87±0.12 0.92±0.16 0.84±0.15 0.84±0.13 0.5271
From last three the table results as can be seen, the hematology of each dosage group and control group and each dosage group and blood parameters testing result there are no significant difference, show that this is tried red blood cell number, leukocyte count and classification, red eggs white content and liver, renal function, the fat metabolism of thing to rat, protein metabolism, glycometabolism all have no adverse effects.
Table 17 the present invention is to the influence of the dirty body ratio of rat
Sex Group ml/kg Number of animals (only) The heart/body Dirty/body Spleen/body Kidney/body Ovary (testis)/body
Female Contrast 30 150 300 P values 10 10 10 10 0.32±0.03 0.29±0.01 0.30±0.02 0.29±0.02 0.0794 3.10±0.21 3.09±0.29 3.14±0.16 3.02±0.24 0.7177 0.22±0.03 0.22±0.01 0.23±0.02 0.22±0.03 0.5181 0.68±0.03 0.67±0.05 0.69±0.02 0.66±0.04 0.3760 0.038±0.006 0.036±0.005 0.037±0.005 0.036±0.004 0.8893
Male Contrast 30 150 300 P values 10 10 10 10 0.31±0.01 0.31±0.01 0.30±0.02 0.29±0.02 0.1774 3.02±0.19 3.02±0.19 3.03±0.24 2.92±0.31 0.6678 0.27±0.04 0.27±0.04 0.26±0.01 0.25±0.04 0.4675 0.69±0.03 0.69±0.03 0.68±0.02 0.66±0.07 0.4339 1.04±0.10 1.04±0.10 1.01±0.09 1.02±0.06 0.7972
From last table as seen, the dirty body between each dosage group and control group and each the dosage group is than there are no significant difference, shows that this is tried thing is grown the internal organs of animal used as test and growth does not have and obviously influences.
Detect demonstration through institute of sports medicine drug-testing center of General Administration of Sport, the present invention does not find to contain stimulant, anesthetic, beta blocker, diuretics and the steroid hormone class medicine of the International Olympic Committee's 2000 regulations.
Comprehensive the above the present invention compared with prior art, the present invention has than the big difference main distinction with prior art on extraction process and is low-light and cryogenic effect, the useful active ingredient that is extracted has also had sizable difference, the health care of being brought into play, health-care effect also have bigger difference and are better than documents and to human body safety.
The specific embodiment
Embodiment 1:
Raw material of the present invention is pilose antler, red date, matrimony vine, sea-buckthorn; With the beverage made is the use amount of criterion calculation raw material for 1 ton, and needing with raw material in the product per ton is the following weight ratio example, 8 kilograms in pilose antler, 60 kilograms of red dates, 15 kilograms of matrimony vines, 50 kilograms of sea-buckthorns, and all the other are water.
Processing technology: after (1) pilose antler was pulverized, at 0 ℃, intensity of illumination was (about 20 watts of light/100 of practical operation meter, 30 luxs 2) down lixiviate 48 hours, filter extract; (2) red date is pulverized the back at 5 ℃, and intensity of illumination be (30 lux) following lixiviate 48 hours, filter extract; (3) after matrimony vine was pulverized, at 5 ℃, intensity of illumination be (30 lux) time lixiviate 48 hours, filter extract; (4) sea-buckthorn directly squeezes into juice, and the extract of four kinds of raw materials mixes, and not enough amount water is supplied and got final product.Filter at last, instantaneous UHTS (145 ℃) three seconds can increase other batching allotment, can, two-stage sterilization if desired again.
Embodiment 2
Raw material of the present invention is pilose antler, red date, matrimony vine, sea-buckthorn; With the beverage made is the use amount of criterion calculation raw material for 1 ton, and needing with raw material in the product per ton is the following weight ratio example, 10 kilograms in pilose antler, 70 kilograms of red dates, 20 kilograms of matrimony vines, 70 kilograms of sea-buckthorns, and all the other are water.
Processing technology: after (1) pilose antler section was pulverized, at 15 ℃, intensity of illumination be (0.5 lux) time lixiviate 40 hours, filter extract; (2) red date is pulverized the back at 15 ℃, and intensity of illumination be (1 lux) following lixiviate 40 hours, filter extract; (3) after matrimony vine was pulverized, at 15 ℃, intensity of illumination be (1 lux) time lixiviate 40 hours, filter extract; (4) sea-buckthorn directly squeezes into juice, and the extract of four kinds of raw materials mixes, and not enough amount water is supplied and got final product.Filter at last, instantaneous UHTS (145 ℃) three seconds can increase other batching allotment, can, two-stage sterilization if desired again.
Embodiment 3
Raw material of the present invention is pilose antler, red date, matrimony vine, sea-buckthorn; With the beverage made is the use amount of criterion calculation raw material for 1 ton, and needing with raw material in the product per ton is the following weight ratio example, 12 kilograms in pilose antler, 80 kilograms of red dates, 25 kilograms of matrimony vines, 90 kilograms of sea-buckthorns, and all the other are water.
Processing technology: after (1) pilose antler was pulverized, at 20 ℃, intensity of illumination be (5 lux) time lixiviate 35 hours, filter extract; (2) red date is pulverized the back at 0 ℃, and intensity of illumination be (10 lux) following lixiviate 35 hours, filter extract; (3) after matrimony vine was pulverized, at 20 ℃, intensity of illumination be (30 lux) time lixiviate 35 hours, filter extract; (4) sea-buckthorn directly squeezes into juice, and the extract of four kinds of raw materials mixes, and not enough amount water is supplied and got final product.Filter at last, instantaneous UHTS (145 ℃) three seconds can increase other batching allotment, can, two-stage sterilization if desired again.
Embodiment 4
Raw material of the present invention is pilose antler, red date, matrimony vine, sea-buckthorn; With the beverage made is the use amount of criterion calculation raw material for 1 ton, and needing with raw material in the product per ton is the following weight ratio example, 12 kilograms in pilose antler, 60 kilograms of red dates, 15 kilograms of matrimony vines, 90 kilograms of sea-buckthorns, and all the other are water.
Processing technology: after (1) pilose antler was pulverized, at 0 ℃, intensity of illumination be (10 lux) time lixiviate 48 hours, filter extract; (2) red date is pulverized the back at 20 ℃, and intensity of illumination be (1 lux) following lixiviate 35 hours, filter extract; (3) after matrimony vine was pulverized, at 0 ℃, intensity of illumination be (10 lux) time lixiviate 40 hours, filter extract; (4) sea-buckthorn directly squeezes into juice, and the extract of four kinds of raw materials mixes, and not enough amount water is supplied and got final product.Filter at last, instantaneous UHTS (145 ℃) three seconds can increase other batching allotment, can, two-stage sterilization if desired again.

Claims (3)

1, a kind of four-in-one health-care beverage is characterized in that: by raw material is that pilose antler, red date, matrimony vine, sea-buckthorn and water are formed; Needing with raw material in the product per ton is the following weight ratio example, 8~12 kilograms in pilose antler, 60~80 kilograms of red dates, 15~25 kilograms of matrimony vines, 50~90 kilograms of sea-buckthorns, and all the other are the water composition.
2, four-in-one health-care beverage according to claim 1 is characterized in that: 8 kilograms in pilose antler, 60 kilograms of red dates, 15 kilograms of matrimony vines, 50 kilograms of sea-buckthorns, all the other are water.
3, a kind of preparation processing technology of four-in-one health-care beverage as claimed in claim 1 or 2 is characterized in that: after (1) pilose antler was pulverized, at 0~20 ℃, intensity of illumination was lixiviate 35~48 hours under 0.5~30 lux, filter extract; (2) red date is pulverized the back at 0~20 ℃, and intensity of illumination is lixiviate 35~48 hours under 0.5~30 lux, filter extract; (3) after matrimony vine was pulverized, at 0~20 ℃, intensity of illumination was lixiviate 35~48 hours under 0.5~30 lux, filter extract; (4) sea-buckthorn directly squeezes into juice, and the extract of four kinds of raw materials mixes, and not enough amount water is supplied and got final product.
CN200610048153A 2006-08-15 2006-08-15 Four-in-one health-care beverage Expired - Fee Related CN1911115B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200610048153A CN1911115B (en) 2006-08-15 2006-08-15 Four-in-one health-care beverage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200610048153A CN1911115B (en) 2006-08-15 2006-08-15 Four-in-one health-care beverage

Publications (2)

Publication Number Publication Date
CN1911115A true CN1911115A (en) 2007-02-14
CN1911115B CN1911115B (en) 2010-05-26

Family

ID=37720314

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200610048153A Expired - Fee Related CN1911115B (en) 2006-08-15 2006-08-15 Four-in-one health-care beverage

Country Status (1)

Country Link
CN (1) CN1911115B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773270A (en) * 2010-03-18 2010-07-14 吴华伟 Antler and rice heath care beverage and preparation method thereof
CN104621556A (en) * 2015-01-08 2015-05-20 无限极(中国)有限公司 Composition with anoxia tolerance and fatigue resistance and application thereof
CN111418829A (en) * 2020-03-31 2020-07-17 中科花鹿农业发展有限公司 Pilose antler blood freeze-dried powder buccal tablet and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083323A (en) * 1992-09-02 1994-03-09 栾斌 Preparation method for natural plant function beverage
CN1086721A (en) * 1992-11-09 1994-05-18 杨玲华 Series beverage by Tricholoma matsutake (lto et lmai) Singer and fructus lycii extracted solution manufacturing
CN1148123C (en) * 2002-05-16 2004-05-05 武生禄 Health-care soup
US20060051461A1 (en) * 2004-09-03 2006-03-09 Jose Antonio Nutrified coffee compositions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773270A (en) * 2010-03-18 2010-07-14 吴华伟 Antler and rice heath care beverage and preparation method thereof
CN104621556A (en) * 2015-01-08 2015-05-20 无限极(中国)有限公司 Composition with anoxia tolerance and fatigue resistance and application thereof
CN111418829A (en) * 2020-03-31 2020-07-17 中科花鹿农业发展有限公司 Pilose antler blood freeze-dried powder buccal tablet and preparation method thereof

Also Published As

Publication number Publication date
CN1911115B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
CN103918965B (en) A kind of beverage of alleviating physical fatigue
CN1400870A (en) Improved pediatric formula and methods for providing nutrition and improving tolerance
CN1911115B (en) Four-in-one health-care beverage
CN1130132C (en) Sobering-up fermented milk beverage and its preparing process
CN1443476A (en) Chinese yam product and its preparation method
CN1973665A (en) Cured fruit-vegetable sauce without cane sugar and its prepn process
CN106418067A (en) Health beverage capable of replenishing physical power and relieving fatigue
CN101731401B (en) Polygonatum instant tea and preparation method thereof
CN1966655A (en) Mulberry fruit vinegar and its production process
CN112042840A (en) Preparation method and application of naked oat oligopeptide and beta-glucan compounded blood sugar reducing beverage
CN101755923B (en) Milk powder having auxiliary hypoglycemic effect
CN103555527B (en) Snake peptide healthcare wine and preparation method thereof
CN1143464A (en) Calcium L-threonate for food additives and preparing process and use thereof
CN1301655C (en) Sugar reducing yoghurt
CN1966069A (en) Application of edestin in preparation of functional food for relieving anemia
CN1067269C (en) Shenmei soft and hard capsule
CN111096344A (en) Sandwich biscuit with function of relieving alcoholic liver injury and preparation method thereof
RU2796461C1 (en) Food product based on natural bee honey
CN1966071A (en) Application of edestin in preparation of anti-anoxia functional food
CN1489925A (en) Concentrated feed for rapidly fattening ruminant
CN100566598C (en) A kind of contain bamboo embryo powder improve health products of anaemia and preparation method thereof
KR101376052B1 (en) The foodstuff composition comprising the extract of Rubus coreanus Miquel or ethyl acetate fraction therefrom for bone growth- promoting
KR101360879B1 (en) Composition containing extract of ribes diacanthum pall. for prevention and treatment of diabetes
CN1168232A (en) Health candy made of royal jelly and pollen
CN1966070A (en) Application of edestin in preparation of medicament

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100526

Termination date: 20110815